Page 153 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 153
YI P0185 ACUTE-ON-CHRONIC LIVER FAILURE NOT ASSOCIATED ePOSTERS
WITH BACTERIAL INFECTIONS. CHARACTERISTICS,
YI P0186 PROGNOSIS AND IMPORTANCE OF SYSTEMIC
YI P0187 INFLAMMATORY RESPONSE
Cristina Solè*, Elsa Sola, Javier Fernandez, Marco Pavesi, Alex Amoros,
YI P0188 Richard Moreau, Paolo Angeli, Rajiv Jalan, Francois Durand,
YI P0189 Thierry Gustot, Faouzi Saliba, Marco Domenicali, Alexander Gerbes,
YI P0190 Julia Wendon, Carlo Alessandria, Wim Laleman, Stefan Zeuzem,
Jonel Trebicka, Mauro Bernardi, Vicente Arroyo, Pere Gines, Spain
A MODEL TO PREDICT MORTALITY IN CIRRHOTICS
PRESENTING WITH CELLULITIS
Cyriac A. Philips*, Ravi Prabhat, Amrish Sahney, Lovkesh Anand,
Devaraja Rangegowda, Awinash Kumar, Guresh Kumar,Vikram Bhatia,
Shiv K. Sarin, India
A RANDOMIZED CONTROLLED TRIAL COMPARING
THE ALFAPUMP© WITH PARACENTESIS IN PATIENTS
WITH REFRACTORY ASCITES: CLINICAL AND
PATHOPHYSIOLOGICAL EFFECTS ON CARDIAC,
HAEMODYNAMIC, INFLAMMATORY, RENAL AND
NUTRITIONAL PARAMETERS
Danielle Adebayo*, Abbas Mohammed, Simran Arora,
Francesco De Chiara, Claudia Trepte, Steve Whitaker, Vibash Mishra,
Daniel Cohen, Dinesh Sharma, Massimo Malago, Rajiv Jalan,
The United Kingdom
HEPATOPULMONARY SYNDROME. PREVALENCE,
ASSOCIATED FACTORS AND IMPACT IN SURVIVAL AFTER
LIVER TRANSPLANTATION
Eva Dueñas*, Rosa Rota, Jesus Ribas, Alex Ruiz-Mayoral,
M Emma González, Alberto Amador, Carme Baliellas, Joan Fabregat,
Xavier Xiol, José Castellote, Spain
PROTON PUMP INHIBITOR TREATMENT IS ASSOCIATED
WITH INCREASED MORTALITY IN PATIENTS WITH
CIRRHOSIS
Georg Dultz*, Albrecht Piiper, Stefan Zeuzem, Bernd Kronenberger,
Oliver Waidmann, Germany
PREDICTIVE MODEL OF MORTALITY IN CIRRHOTIC
PATIENTS WITH HIGH RISK SPONTANEOUS BACTERIAL
PERITONITIS
Maria Poca*, Edilmar Alvarado, Mar Concepción, Cristina Pérez-
Cameo, Núria Cañete, Ignasi J Gich, Cristina Romero, Meritxell Casas,
Eva Román, Luís Castells, Víctor Vargas, José A Carrión, Carlos Guarner,
German Soriano, Spain
Vienna, Austria • April 22–26, 2015 153
WITH BACTERIAL INFECTIONS. CHARACTERISTICS,
YI P0186 PROGNOSIS AND IMPORTANCE OF SYSTEMIC
YI P0187 INFLAMMATORY RESPONSE
Cristina Solè*, Elsa Sola, Javier Fernandez, Marco Pavesi, Alex Amoros,
YI P0188 Richard Moreau, Paolo Angeli, Rajiv Jalan, Francois Durand,
YI P0189 Thierry Gustot, Faouzi Saliba, Marco Domenicali, Alexander Gerbes,
YI P0190 Julia Wendon, Carlo Alessandria, Wim Laleman, Stefan Zeuzem,
Jonel Trebicka, Mauro Bernardi, Vicente Arroyo, Pere Gines, Spain
A MODEL TO PREDICT MORTALITY IN CIRRHOTICS
PRESENTING WITH CELLULITIS
Cyriac A. Philips*, Ravi Prabhat, Amrish Sahney, Lovkesh Anand,
Devaraja Rangegowda, Awinash Kumar, Guresh Kumar,Vikram Bhatia,
Shiv K. Sarin, India
A RANDOMIZED CONTROLLED TRIAL COMPARING
THE ALFAPUMP© WITH PARACENTESIS IN PATIENTS
WITH REFRACTORY ASCITES: CLINICAL AND
PATHOPHYSIOLOGICAL EFFECTS ON CARDIAC,
HAEMODYNAMIC, INFLAMMATORY, RENAL AND
NUTRITIONAL PARAMETERS
Danielle Adebayo*, Abbas Mohammed, Simran Arora,
Francesco De Chiara, Claudia Trepte, Steve Whitaker, Vibash Mishra,
Daniel Cohen, Dinesh Sharma, Massimo Malago, Rajiv Jalan,
The United Kingdom
HEPATOPULMONARY SYNDROME. PREVALENCE,
ASSOCIATED FACTORS AND IMPACT IN SURVIVAL AFTER
LIVER TRANSPLANTATION
Eva Dueñas*, Rosa Rota, Jesus Ribas, Alex Ruiz-Mayoral,
M Emma González, Alberto Amador, Carme Baliellas, Joan Fabregat,
Xavier Xiol, José Castellote, Spain
PROTON PUMP INHIBITOR TREATMENT IS ASSOCIATED
WITH INCREASED MORTALITY IN PATIENTS WITH
CIRRHOSIS
Georg Dultz*, Albrecht Piiper, Stefan Zeuzem, Bernd Kronenberger,
Oliver Waidmann, Germany
PREDICTIVE MODEL OF MORTALITY IN CIRRHOTIC
PATIENTS WITH HIGH RISK SPONTANEOUS BACTERIAL
PERITONITIS
Maria Poca*, Edilmar Alvarado, Mar Concepción, Cristina Pérez-
Cameo, Núria Cañete, Ignasi J Gich, Cristina Romero, Meritxell Casas,
Eva Román, Luís Castells, Víctor Vargas, José A Carrión, Carlos Guarner,
German Soriano, Spain
Vienna, Austria • April 22–26, 2015 153
